CIROK INJECTION 2 mgml

Maa: Singapore

Kieli: englanti

Lähde: HSA (Health Sciences Authority)

Osta se nyt

Lataa Valmisteyhteenveto (SPC)
28-10-2022

Aktiivinen ainesosa:

CIPROFLOXACIN

Saatavilla:

ZIWELL MEDICAL (S) PTE LTD

ATC-koodi:

J01MA02

Annos:

2 mg/ml

Lääkemuoto:

INJECTION

Koostumus:

CIPROFLOXACIN 2 mg/ml

Antoreitti:

INTRAVENOUS

Prescription tyyppi:

Prescription Only

Valmistaja:

KOREA UNITED PHARMACEUTICAL INC

Valtuutuksen tilan:

ACTIVE

Valtuutus päivämäärä:

2002-03-15

Valmisteyhteenveto

                                CIROK INJ.
CIPROFLOXACIN 2MG/ML
COMPOSITION
Each mL contains
Ciprofloxacin
……………………………………………………………………………..
‥
2 mg
DESCRIPTION
Clear, colorless to pale yellow solution in a vial.
INDICATIONS
CIROK is indicated for the treatment of the following infections
caused by sensitive bacteria.
Severe systemic infections eg septicemia. Respiratory tract infection
eg pneumonia. Urinary
tract infection. Skin and soft tissue infections. Intra-abdominal
infection. Bone and joint
infection.
DOSAGE AND ADMINISTRATIONS
General dosage recommendeds : The dosage of ciprofloxacin is
determined by the severity
and type of infection, the sensitivity of the causative organism(s)
and the age, weight and
renal function of the patient.
The recommended adult dosage for urinary tract infections of mild to
moderate severity is
200 mg every 12 hours. For severe or complicated urinary tract
infections the recommended
dosage is 400 mg every 12 hours.
The recommended adult dosage for lower respiratory tract infections,
skin and skin structure
infections and bone and joint infections of mild to moderate severity
is 400 mg every 12
hours.
The usual duration is 7 to 14 days. Bone and joint infections may
require treatment for 4 to 6
weeks or longer. And should be treated for at least 2 days after the
signs and symptoms of
the infection have disappeared.
CIROK should be administered by intravenous infusion over a period 60
minutes.
Impaired Renal function :
The following table provides dosage guidelines for use in patients
with renal impairment :
monitoring of serum drug level provides the most reliable basis for
dosage adjustment.
Creatinine Clearance
(mL/min)
Dosage
≥ 30
5 - 29
See usual dosage
200 – 400 mg q 18 – 24 hr
When only the serum creatinine concentration is known, the following
formula may be used
to estimate creatinine clearance.
-
Men : Creatinine Clearance
Weight(kg) × (140-age)
(mL/min) =
72 × Serum creatinine (mg/dL)
-
Women : 0.85 × the value calculated for men.
Ini
                                
                                Lue koko asiakirja
                                
                            

Etsi tähän tuotteeseen liittyviä ilmoituksia